These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 656635)

  • 21. Influence of cytotoxic drugs on platelet functions and coagulation in vitro. IV. Melphalan.
    Klener P; Kubisz P; Suranová J
    Thromb Haemost; 1977 Feb; 37(1):53-61. PubMed ID: 576517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of heparin and aspirin on platelet and clotting activation during leukapheresis.
    Fabris F; Casonato A; Randi ML; Belloni M; Quaino V; Ongaro G; Girolami A
    Eur J Clin Invest; 1985 Aug; 15(4):188-91. PubMed ID: 2931280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter.
    Arcangeli A; Rocca B; Salvatori G; Ciancia M; De Cristofaro R; Antonelli M
    Thromb Res; 2010 Jul; 126(1):24-31. PubMed ID: 20185164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that colagen releases human platelet constituents by two different mechanisms.
    Huzoor-Akbar ; Ardlie NG
    Br J Haematol; 1976 Sep; 34(1):137-46. PubMed ID: 952763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The in vitro effects of Xancor, a synthetic astaxanthine derivative, on hemostatic biomarkers in aspirin-naïve and aspirin-treated subjects with multiple risk factors for vascular disease.
    Serebruany V; Malinin A; Goodin T; Pashkow F
    Am J Ther; 2010; 17(2):125-32. PubMed ID: 20305399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clotting and fibrinolysis.
    Prentice CR
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():50-3. PubMed ID: 182726
    [No Abstract]   [Full Text] [Related]  

  • 27. The interaction of varying doses of dipyridamole and acetyl salicylic acid on the inhibition of platelet functions and their effect on bleeding time.
    Rajah SM; Penny AF; Crow MJ; Pepper MD; Watson DA
    Br J Clin Pharmacol; 1979 Nov; 8(5):483-9. PubMed ID: 508556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary giant platelet syndrome. Absence of collagen-induced coagulant activity and deficiency of factor-XI binding to platelets.
    Walsh PN; Mills DC; Pareti FI; Stewart GJ; Macfarlane DE; Johnson MM; Egan JJ
    Br J Haematol; 1975 Apr; 29(4):639-55. PubMed ID: 1191567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scanning electron microscopy of crush/avulsion arterial trauma:effect of heparin and aspirin administration.
    Cooley BC; Ruas EJ; Wilgis EF
    Microsurgery; 1987; 8(1):11-6. PubMed ID: 3586988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes of platelet function, coagulation and fibrinolysis during induction of labour at term by prostaglandin F2alpha and oxytocin (author's transl)].
    Briel RC; Kidess E; Kunz S
    Z Geburtshilfe Perinatol; 1978 Jun; 182(3):238-42. PubMed ID: 80063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous testing of the heparin effect on the soluble phase and platelet component of hemostasis.
    Melton LG; Gabriel DA; Dehmer GJ
    Am J Med Sci; 2003 Dec; 326(6):345-52. PubMed ID: 14671498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis. I. In vitro experiments.
    De Clerck F; Vermylen J; Reneman R
    Arch Int Pharmacodyn Ther; 1975 Aug; 216(2):263-79. PubMed ID: 1180617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis II. In vivo experiments.
    De Clerck F; Vermylen J; Reneman R
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):68-79. PubMed ID: 1190914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular weight of heparin versus biologic activity. Some additional considerations.
    Losito R; Losito C
    Semin Thromb Hemost; 1985 Jan; 11(1):29-33. PubMed ID: 2579437
    [No Abstract]   [Full Text] [Related]  

  • 35. [Study of the increased efficacy of heparin due to carbenicillin].
    Wamhoff D
    Z Gesamte Inn Med; 1975 Oct; 30(20):687-9. PubMed ID: 1216951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet function and pharmacologic inhibition.
    Chaer RA; Graham JA; Mureebe L
    Vasc Endovascular Surg; 2006; 40(4):261-7. PubMed ID: 16959718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of dienogest on bleeding time, coagulation, fibrinolysis, and platelet aggregation in female rats.
    Nobukata H; Katsuki Y; Ishikawa T; Inokuma M; Shibutani Y
    Toxicol Lett; 1999 Jan; 104(1-2):93-101. PubMed ID: 10048754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of factor VIII concentrate on malondialdehyde release by normal human platelets].
    Geroldi D; Cervini L
    Boll Soc Ital Biol Sper; 1979 Apr; 55(7):675-81. PubMed ID: 121702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coagulation, fibrinolytic and platelet function in patients on long-term therapy with aspirin 300 mg or 1,200 mg daily compared with placebo.
    Hampton KK; Cerletti C; Loizou LA; Bucchi F; Donati MB; Davies JA; de Gaetano G; Prentice CR
    Thromb Haemost; 1990 Aug; 64(1):17-20. PubMed ID: 2073296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formation.
    Mojica Muñoz AK; Jamasbi J; Uhland K; Degen H; Münch G; Ungerer M; Brandl R; Megens R; Weber C; Lorenz R; Siess W
    Thromb Haemost; 2017 Aug; 117(8):1651-1659. PubMed ID: 28569920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.